HCV in the Australian primary care setting: real-world effectiveness of 12 weeks of sofosbuvir/velpatasvir for the treatment of chronic hepatitis C

被引：0

作者：

O'Loan, Joss ^{[1
,2
]}

Balcomb, Anne ^{[3
]}

Baker, David ^{[4
]}

Doyle, Joseph ^{[5
,6
]}

Godfrey, Daniel ^{[7
]}

Kozminsky, Michael ^{[8
]}

Mertens, Michael ^{[9
]}

Vanstraelen, Kim ^{[9
]}

Young, Matt ^{[1
,2
]}

机构：

[1] Med Clin, Inala, Australia

[2] Kombi Clin, Brisbane, Qld, Australia

[3] Prince St Clin, Orange, NSW, Australia

[4] East Sydney Doctors, Darlinghurst, NSW, Australia

[5] Alfred, Melbourne, Vic, Australia

[6] Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia

[7] Gilead Sci Pty Ltd, Melbourne, Vic, Australia

[8] Genesis Med Ctr, Brighton, Australia

[9] Gilead Sci Ltd, London, England

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU419

引用

页码：S346 / S346

页数：1

共 50 条

[41] Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
Chen-Hua Liu
Po-Yueh Chen
Jyh-Jou Chen
Ching-Chu Lo
Wei-Wen Su
Kuo-Chih Tseng
Chun-Jen Liu
Chia-Sheng Huang
Ke-Jhang Huang
Sheng-Shun Yang
Cheng-Yuan Peng
Ming-Chang Tsai
Wei-Yu Kao
Chi-Yang Chang
Yu-Lueng Shih
Yu-Jen Fang
Chi-Yi Chen
Pei-Lun Lee
Jow-Jyh Huang
Pei-Yuan Su
Chi-Wei Tseng
Chien-Ching Hung
Chung-Hsin Chang
Yi-Jie Huang
Hsueh-Chou Lai
Chun-Chao Chang
Fu-Jen Lee
Tsai‐Yuan Hsieh
Jia-Horng Kao
Hepatology International, 2021, 15 : 338 - 349
[42] Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts
Mangia, Alessandra
Milligan, Scott
Khalili, Mandana
Fagiuoli, Stefano
Shafran, Stephen D.
Carrat, Fabrice
Ouzan, Denis
Papatheodoridis, George
Ramji, Alnoor
Borgia, Sergio M.
Wedemeyer, Heiner
Losappio, Ruggero
Perez-Hernandez, Francisco
Wick, Nicole
Brown, Robert S., Jr.
Lampertico, Pietro
Doucette, Karen
Ntalla, Ioanna
Ramroth, Heribert
Mertens, Michael
Vanstraelen, Kim
Turnes, Juan
LIVER INTERNATIONAL, 2020, 40 (08) : 1841 - 1852
[43] Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
Liu, Chen-Hua
Chen, Po-Yueh
Chen, Jyh-Jou
Lo, Ching-Chu
Su, Wei-Wen
Tseng, Kuo-Chih
Liu, Chun-Jen
Huang, Chia-Sheng
Huang, Ke-Jhang
Yang, Sheng-Shun
Peng, Cheng-Yuan
Tsai, Ming-Chang
Kao, Wei-Yu
Chang, Chi-Yang
Shih, Yu-Lueng
Fang, Yu-Jen
Chen, Chi-Yi
Lee, Pei-Lun
Huang, Jow-Jyh
Su, Pei-Yuan
Tseng, Chi-Wei
Hung, Chien-Ching
Chang, Chung-Hsin
Huang, Yi-Jie
Lai, Hsueh-Chou
Chang, Chun-Chao
Lee, Fu-Jen
Hsieh, Tsai-Yuan
Kao, Jia-Horng
HEPATOLOGY INTERNATIONAL, 2021, 15 (02) : 338 - 349
[44] Sofosbuvir/velpatasvir/voxilaprevir in the treatment of chronic hepatitis C infection
Kilaru, Saikiran M.
Jacobson, Ira M.
FUTURE VIROLOGY, 2019, 14 (02) : 61 - 71
[45] Effectiveness of Sofosbuvir and Velpatasvir Combination in Chronic Hepatitis C with Hemodialysis Patients
Khan, Rahmat Ali
Ali, Anwar
Munib, Syed
Muhammad, Iftikhar
Nosherwan
Ali, Amjad
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (05): : 1205 - 1207
[46] REAL-WORLD EXPERIENCE WITH LEDIPASVIR/SOFOSBUVIR COMBINATION AND SOFOSBUVIR/VELPATASVIR COMBINATOIN IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 6 PATIENTS IN THE UNITED STATES
Nguyen, Emily
Trinh, Sam
Trinh, Huy N.
Khanh Nguyen
Levitt, Brian
My Nguyen
Purohit, Treta
Shieh, Eugenie
Nguyen, Mindie H.
GASTROENTEROLOGY, 2018, 154 (06) : S1189 - S1189
[47] Effectiveness of Sofosbuvir / Velpatasvir in Treating Hepatitis C Virus Infection in RealWorld Setting
Janjua, Naveed
Wong, Stanley
Yu, Amanda
Butt, Zahid Ahmad
Rossi, Carmine
Alvarez, Maria
Binka, Mawuena
Darvishian, Maryam
Chapinal, Nuria
Cook, Darrel
Yoshida, Eric M.
Ramji, Alnoor
Tyndall, Mark
Krajden, Mel
HEPATOLOGY, 2018, 68 : 362A - 362A
[48] Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection
Matthews, Gail V.
Bhagani, Sanjay
Van der Valk, Marc
Rockstroh, Juergen
Feld, Jordan J.
Rauch, Andri
Thurnheer, Christine
Bruneau, Julie
Kim, Arthur
Hellard, Margaret
Shaw, David
Gane, Ed
Nelson, Mark
Ingiliz, Patrick
Applegate, Tanya L.
Grebely, Jason
Marks, Phillipa
Martinello, Marianne
Petoumenos, Kathy
Dore, Gregory J.
JOURNAL OF HEPATOLOGY, 2021, 75 (04) : 829 - +
[49] Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
Yuki Tahata
Hayato Hikita
Satoshi Mochida
Norifumi Kawada
Nobuyuki Enomoto
Akio Ido
Hitoshi Yoshiji
Daiki Miki
Yoichi Hiasa
Yasuhiro Takikawa
Ryotaro Sakamori
Masayuki Kurosaki
Hiroshi Yatsuhashi
Ryosuke Tateishi
Yoshiyuki Ueno
Yoshito Itoh
Taro Yamashita
Tatsuya Kanto
Goki Suda
Yasunari Nakamoto
Naoya Kato
Yasuhiro Asahina
Kentaro Matsuura
Shuji Terai
Kazuhiko Nakao
Masahito Shimizu
Taro Takami
Norio Akuta
Ryoko Yamada
Takahiro Kodama
Tomohide Tatsumi
Tomomi Yamada
Tetsuo Takehara
Journal of Gastroenterology, 2021, 56 : 67 - 77
[50] Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
Tahata, Yuki
Hikita, Hayato
Mochida, Satoshi
Kawada, Norifumi
Enomoto, Nobuyuki
Ido, Akio
Yoshiji, Hitoshi
Miki, Daiki
Hiasa, Yoichi
Takikawa, Yasuhiro
Sakamori, Ryotaro
Kurosaki, Masayuki
Yatsuhashi, Hiroshi
Tateishi, Ryosuke
Ueno, Yoshiyuki
Itoh, Yoshito
Yamashita, Taro
Kanto, Tatsuya
Suda, Goki
Nakamoto, Yasunari
Kato, Naoya
Asahina, Yasuhiro
Matsuura, Kentaro
Terai, Shuji
Nakao, Kazuhiko
Shimizu, Masahito
Takami, Taro
Akuta, Norio
Yamada, Ryoko
Kodama, Takahiro
Tatsumi, Tomohide
Yamada, Tomomi
Takehara, Tetsuo
JOURNAL OF GASTROENTEROLOGY, 2021, 56 (01) : 67 - 77

← 1 2 3 4 5 →